Expression and clinical significance of c-FLIP in hematologic malignancies
SONG Min,WANG Jian-ning,MENG Qing-qi,BAO Hong-yu,LU Hua
DOI: https://doi.org/10.3969/j.issn.1003-6350.2014.23.1347
2014-01-01
Journal of Modern Oncology
Abstract:Objective To explore c-FLIP (cellular FLICE inhibitory protein) expression and its clinical sig-nificance in hematologic malignancies. Methods Expression level of c-FLIP mRNA and protein in bone marrow mononuclear cells was determined by Semi-Reverse Transcription-Polymerase Chain Reaction (Semi-RT-PCR) and Western blot in 22 patients of hematologic malignancies, which included 11 cases with newly diagnosed acute leuke-mia (AL), 1 case of relapsed AL, 2 cases of AL after complete remission (CR), 2 cases of chronic myelocytic leukemia (CML), 2 cases of chronic lymphocytic leukemia (CLL), 2 cases of multiple myeloma (MM) and 2 cases of mycelo-dysplastic syndrome-refractory anemia with excess blasts-2 (MDS-RAEB-2). Results Expression level of c-FLIP mRNA and protein were higher in patients with newly diagnosed or relapsed AL and newly diagnosed CML, CLL, MDS-RAEB-2, MM. Levels of c-FLIP mRNA and protein of 43 kD were higher in AL than in newly diagnosed chron-ic leukemia (CL), P<0.05. There were no significant differences in mRNA between MDS-RAEB-2, MM and AL (P>0.05). The levels of c-FLIP protein of 55 kD and 43 kD were lower in MDS than those in newly diagnosed AL (P<0.05). The expression of normal subjects in mRNA and protein were negative. The expression of AL after CR was neg-ative in mRNA, but positive in protein, and lower than AL, especially in protein of 43 kD (P<0.05). The expression level of c-FLIP was not associated with age, sex, WBC, LDH, cytogenetic characteristics, immunophenotype (P>0.05). There were no significant differences in that of curative effect (P>0.05). Conclusion c-FLIP was highly ex-pressed in hematologic malignancies. The level of expression reflected apoptosis of hematologic malignancies, and was closely related with the type and situation of hematologic malig-nancies, chemotherapeutic effects and prognosis.